Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Viridian Therapeutics, Inc.\DE | exh_321.htm |
| EX-31.1 - EXHIBIT 31.1 - Viridian Therapeutics, Inc.\DE | exh_311.htm |
| EX-10.29 - EXHIBIT 10.29 - Viridian Therapeutics, Inc.\DE | exh_1029.htm |
| EX-10.28 - EXHIBIT 10.28 - Viridian Therapeutics, Inc.\DE | exh_1028.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Viridian Therapeutics, Inc.\DE | Financial_Report.xls |
| 10-K - FORM 10-K - Viridian Therapeutics, Inc.\DE | f10k_032615.htm |
| EX-31.2 - EXHIBIT 31.2 - Viridian Therapeutics, Inc.\DE | exh_312.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Signal Genetics, Inc.
Carlsbad, California
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No.333-197316) of Signal Genetics, Inc. Inc. of our report dated March 27, 2015, relating to the consolidated financial statements which appears in this Annual Report on Form 10-K for the year ended December 31, 2014.
/s/ BDO USA, LLP
New York, New York
March 27, 2015